A METHOD FOR TREATING OR PREVENTING SYMPTOMS OF HORMONAL VARIATION INCLUDES ADMINISTERING AN EFFECTIVEAMOUNT OF A RECEPTOR ANTAGONIST TO A SUBJECT HAVING ONE OR MORE SYMPTOMS OF HORMONAL VARIATIONS, WHEREIN THE RECEPTOR ANTAGONIST BINDS TO AT LEAST ONE SELECTED FROM TILE GROUP CONSISTING OF A SEROTONIN TYPE 2A (5-HT2A) AND A DOPAMINE TYPE 2 (D2) RECEPTORS.